Ibrahim Nassour, MD, MSCS - Research

Research at a glance

Top areas of exploration

Pancreatic Neoplasms , 23 publications
Adenocarcinoma , 17 publications
Robotic Surgical Procedures , 12 publications
Pancreaticoduodenectomy , 12 publications

Research activity

92 publications

1,539 citations

Why is this important?

Active clinical trials

Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer

This phase III trial compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer that can be removed by surgery (removable/resectable). Chemotherapy鈥�

Investigator: Ibrahim Nassour
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: All

My publications

92 publications

2021

Pathologic Complete Response Following Neoadjuvant Therapy for Gastric Adenocarcinoma: A National Cancer Database Analysis on Incidence, Predictors, and Outcomes.

The American surgeon

鈥�

2021

Patient Factors Limit Colon Cancer Survival at Safety-Net Hospitals: A National Analysis.

The Journal of surgical research

鈥�

2021

Perioperative and oncologic outcomes of open, laparoscopic, and robotic distal pancreatectomy for pancreatic adenocarcinoma.

Updates in surgery

鈥�

2021

Predictors of early recurrence following neoadjuvant chemotherapy and surgical resection for localized pancreatic adenocarcinoma

Journal of Surgical Oncology

鈥�

2021

Safety and oncologic efficacy of robotic compared to open pancreaticoduodenectomy after neoadjuvant chemotherapy for pancreatic cancer

Surgical Endoscopy

网红黑料

Ibrahim Nassour, MD, MSCS : Research

Research at a glance

Top areas of exploration

Research activity

Active clinical trials

My publications

Pathologic Complete Response Following Neoadjuvant Therapy for Gastric Adenocarcinoma: A National Cancer Database Analysis on Incidence, Predictors, and Outcomes.

Patient Factors Limit Colon Cancer Survival at Safety-Net Hospitals: A National Analysis.

Perioperative and oncologic outcomes of open, laparoscopic, and robotic distal pancreatectomy for pancreatic adenocarcinoma.

Predictors of early recurrence following neoadjuvant chemotherapy and surgical resection for localized pancreatic adenocarcinoma

Safety and oncologic efficacy of robotic compared to open pancreaticoduodenectomy after neoadjuvant chemotherapy for pancreatic cancer

网红黑料

Research at a glance

Top areas of exploration

Research activity

Active clinical trials

My publications

Filter publications

Pathologic Complete Response Following Neoadjuvant Therapy for Gastric Adenocarcinoma: A National Cancer Database Analysis on Incidence, Predictors, and Outcomes.

Patient Factors Limit Colon Cancer Survival at Safety-Net Hospitals: A National Analysis.

Perioperative and oncologic outcomes of open, laparoscopic, and robotic distal pancreatectomy for pancreatic adenocarcinoma.

Predictors of early recurrence following neoadjuvant chemotherapy and surgical resection for localized pancreatic adenocarcinoma

Safety and oncologic efficacy of robotic compared to open pancreaticoduodenectomy after neoadjuvant chemotherapy for pancreatic cancer